Skip to main content
. 2022 Aug 15;61(16):2405–2415. doi: 10.2169/internalmedicine.8560-21

Figure 4.

Figure 4.

Changes in the BMD from baseline to 12 months in patients treated with denosumab by glucocorticoid dose. Glucocorticoid doses are expressed in mg/day of prednisolone equivalent. Data are expressed as the median with 25th to 75th percentiles.